World's Best Scientists 2026 revealed!
Giovanni Cazzaniga

Giovanni Cazzaniga

D-Index & Metrics

Biology and Biochemistry

D-Index
77
Citations
26067
World Ranking
4711
National Ranking
104

Overview

Giovanni Cazzaniga is affiliated with the University of Milano-Bicocca in Italy. Their research spans a broad spectrum within medicine, with a particular focus on hematology and molecular biology. Their work addresses significant areas such as acute lymphoblastic leukemia (ALL), acute myeloid leukemia, chronic myeloid leukemia, and chronic lymphocytic leukemia, as well as topics related to childhood cancer survivors' quality of life and CAR-T cell therapy research.

Their publication record is strong in leading journals, with frequent contributions to Blood, Leukemia, HemaSphere, Experimental Hematology, and the International Journal of Molecular Sciences.

Among recent notable papers authored or co-authored by Giovanni Cazzaniga are:

  • The KMT2A recombinome of acute leukemias in 2023, Leukemia
  • Sleeping Beauty-engineered CAR T cells achieve antileukemic activity without severe toxicities, 2020, Journal of Clinical Investigation
  • Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study, 2021, Leukemia
  • The Bone Marrow Niche in B-Cell Acute Lymphoblastic Leukemia: The Role of Microenvironment from Pre-Leukemia to Overt Leukemia, 2021, International Journal of Molecular Sciences
  • Remission, treatment failure, and relapse in pediatric ALL: an international consensus of the Ponte-di-Legno Consortium, 2021, Blood

Frequent collaborators include several researchers with whom Giovanni Cazzaniga has co-authored numerous publications, including:

  • Andrea Biondi
  • Grazia Fazio
  • Maria Grazia Valsecchi
  • Michela Bardini
  • Chiara Palmi

Their work integrates diverse subfields such as public health, environmental and occupational health, hematology, molecular biology, genetics, and oncology. This interdisciplinary approach supports their contributions to fields like acute leukemia research and cancer treatment strategies, including the development and investigation of CAR-T cell therapies.

Best Publications

  • Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program

    J Gabert;E Beillard;V H J van der Velden;W Bi

  • Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood

    Jacques Jm van Dongen;Taku Seriu;E Renate Panzer-Grümayer;Andrea Biondi

  • Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

    Valentino Conter;Claus R. Bartram;Maria Grazia Valsecchi;Andre Schrauder

  • Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data.

    V H J van der Velden;G Cazzaniga;A Schrauder;J Hancock

  • Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects.

    V H J van der Velden;A Hochhaus;G Cazzaniga;T Szczepanski

  • Prenatal origin of acute lymphoblastic leukaemia in children

    JL Wiemels;G Cazzaniga;M Daniotti;OB Eden

  • The MLL recombinome of acute leukemias in 2013

    C. Meyer;J. Hofmann;T. Burmeister;D. Gröger

  • Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study

    Martin Schrappe;Maria Grazia Valsecchi;Claus R. Bartram;André Schrauder

  • Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia.

    T Flohr;T Flohr;A Schrauder;G Cazzaniga;R Panzer-Grümayer

  • Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia

    Elisabetta Flex;Valentina Petrangeli;Lorenzo Stella;Sabina Chiaretti

  • RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia

    Elli Papaemmanuil;Inmaculada Rapado;Yilong Li;Nicola E Potter

  • Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias

    Chen Shochat;Noa Tal;Noa Tal;Obul R. Bandapalli;Obul R. Bandapalli;Chiara Palmi

  • Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome

    Dani Bercovich;Ithamar Ganmore;Linda M. Scott;Gilad Wainreb

  • Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials

    Arndt Borkhardt;Giovanni Cazzaniga;Susanne Viehmann;Maria Grazia Valsecchi

  • Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML.

    Brunangelo Falini;Niccolò Bolli;Jing Shan;Maria Paola Martelli

  • Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations

    Paolo Gorello;G. Cazzaniga;F. Alberti;M. G. Dell'Oro

  • Genetic evidence for lineage-related and differentiation stage–related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia

    Marco Tartaglia;Simone Martinelli;Giovanni Cazzaniga;Viviana Cordeddu

  • Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group

    Libi Hertzberg;Libi Hertzberg;Libi Hertzberg;Elena Vendramini;Ithamar Ganmore;Ithamar Ganmore;Giovanni Cazzaniga

  • Molecular Analysis of the Progression from Helicobacter pylori–Associated Chronic Gastritis to Mucosa-Associated Lymphoid-Tissue Lymphoma of the Stomach

    Emanuele Zucca;Francesco Bertoni;Enrico Roggero;Giovanna Bosshard

  • Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemia

    Cornelia Eckert;Andrea Biondi;Karlheinz Seeger;Giovanni Cazzaniga

Frequent Co-Authors

Andrea Biondi
Andrea Biondi University of Milano-Bicocca
Giuseppe Basso
Giuseppe Basso University of Padua
Maria Grazia Valsecchi
Maria Grazia Valsecchi University of Milano-Bicocca
Martin Schrappe
Martin Schrappe Kiel University
Martin Stanulla
Martin Stanulla Hannover Medical School
Hélène Cavé
Hélène Cavé Université Paris Cité
Mel Greaves
Mel Greaves Institute of Cancer Research
Jan Trka
Jan Trka Charles University
Oskar A. Haas
Oskar A. Haas Medical University of Vienna
Andrea Pession
Andrea Pession University of Bologna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Biology or Biochemistry opens the door to a variety of career options beyond research and clinical roles. There is growing demand for professionals who blend science with technology and data management in healthcare. If you’re interested in pivoting toward healthcare administration, consider the online health information management degree as an affordable and flexible pathway.

Medical coding and billing careers are also popular choices for science graduates. There are different medical coding certification options, such as CPC and CCS, each with costs and salary prospects you’ll want to compare. If you are wondering how long does it take to become a medical coder, the process can be completed in a matter of months with the right training.

Many find this field rewarding, but you may also want to explore whether is medical coding a good job for your interests and long-term growth. Whichever path you choose, online programs offer the flexibility to upskill while building on your scientific background.

Best Scientists Citing Giovanni Cazzaniga

Trending Scientists

Recently Published Articles